Artificial Genes

Biotech comes to the drugstore

Skeptics have wondered whether genetically engineered drugs might become the synfuels of the 1980s, crippled by uneconomical costs and uncertain usefulness. Now there is early evidence that the skeptics may be wrong. Genentech, an industry leader, licensed for sale a gene-spliced substance that has just become the first such medicine ever approved for human use by the U.S. Food and Drug Administration. Says Dr. John Potts, professor at Harvard Medical School and chief of medical services at Massachusetts General Hospital: "This is really a landmark because it is...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!